Pfizer Newsroom

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $31 to $33

Futu NewsOct 31 21:20

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $30 to $36

Futu NewsOct 30 21:12

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating

Futu NewsOct 29 20:33

Pfizer Analyst Ratings

BenzingaOct 25 23:55

Cantor Fitzgerald Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $45

Futu NewsOct 25 20:31

Pfizer (PFE) Gets a Buy From Cantor Fitzgerald

TipRanksOct 25 20:30

Citi Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 25 19:35

J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 25 07:34

Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 24 18:32

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaOct 24 00:32

Pfizer Analyst Ratings

BenzingaOct 24 00:30

Hold Recommendation on Pfizer Amid Promising but Early Stage Cancer Cachexia Drug Development

TipRanksOct 23 14:47

Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 22 18:31

Mixed Prospects and Uncertainty Lead to Hold Rating for Pfizer Amid COVID-19 Revenue Fluctuations

TipRanksOct 22 18:07

Goldman Sachs Adjusts Price Target on Pfizer to $32 From $34

MT NewswiresOct 21 20:27

Pfizer Analyst Ratings

BenzingaOct 17 19:45

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Futu NewsOct 11 20:33

Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $30

Futu NewsOct 11 20:31

Jefferies Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksOct 11 20:05

Pfizer's Leadership Stability and Activist Investor Watch: A Hold Rating Analysis

TipRanksOct 11 15:20